Shanghai, China

Guoqing Zhang

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Shenzhen, CN (2021 - 2022)
  • Shanghai, CN (2018 - 2023)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Guoqing Zhang: Innovator in Guanylate Cyclase C Agonists

Introduction

Guoqing Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biochemistry, particularly in the development of ultra-pure agonists of guanylate cyclase C. With a total of nine patents to his name, Zhang's work has the potential to impact various therapeutic applications.

Latest Patents

Zhang's latest patents focus on the purification processes of peptides that include a guanylate cyclase C agonist sequence. The inventions provide detailed methodologies for purifying these peptides, which include a solvent exchange step prior to freeze-drying, or lyophilization. This innovative approach enhances the purity and efficacy of the agonists, making them valuable for research and clinical applications.

Career Highlights

Throughout his career, Guoqing Zhang has worked with notable companies such as Bausch Health Ireland Limited and Huawei Technologies Co., Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Zhang has collaborated with esteemed colleagues, including Kunwar Shailubhai and Stephen Comiskey. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Guoqing Zhang's contributions to the field of guanylate cyclase C agonists exemplify his dedication to advancing biochemistry. His innovative patents and collaborations highlight his role as a key figure in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…